130 related articles for article (PubMed ID: 11021392)
1. Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime.
Akiyama M; Oishi K; Tao M; Matsumoto K; Pollack M
Microbiol Immunol; 2000; 44(8):629-35. PubMed ID: 11021392
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice.
Oishi K; Sonoda F; Miwa H; Tanaka H; Watanabe K; Matsumoto K; Pollack M
Microbiol Immunol; 1991; 35(12):1131-41. PubMed ID: 1808464
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin.
Ishibashi K; Yamaguchi O; Shiraiwa Y; Ogihara M; Shigeta S
J Urol; 1996 Jun; 155(6):2094-7. PubMed ID: 8618343
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
[TBL] [Abstract][Full Text] [Related]
5. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.
Stoll BJ; Pollack M; Young LS; Koles N; Gascon R; Pier GB
Infect Immun; 1986 Sep; 53(3):656-62. PubMed ID: 2427453
[TBL] [Abstract][Full Text] [Related]
6. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity.
Oishi K; Koles NL; Guelde G; Pollack M
J Infect Dis; 1992 Jan; 165(1):34-45. PubMed ID: 1727896
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia.
Oishi K; Sonoda F; Iwagaki A; Ponglertnapagorn P; Watanabe K; Nagatake T; Siadak A; Pollack M; Matsumoto K
Antimicrob Agents Chemother; 1993 Feb; 37(2):164-70. PubMed ID: 8383936
[TBL] [Abstract][Full Text] [Related]
9. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
Collins MS; Ladehoff DK; Mehton NS; Noonan JS
FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.
Pier GB; Thomas D; Small G; Siadak A; Zweerink H
Infect Immun; 1989 Jan; 57(1):174-9. PubMed ID: 2491835
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.
Pollack M; Koles NL; Preston MJ; Brown BJ; Pier GB
Infect Immun; 1995 Nov; 63(11):4481-8. PubMed ID: 7591089
[TBL] [Abstract][Full Text] [Related]
13. Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia.
Pennington JE; Small GJ; Lostrom ME; Pier GB
Infect Immun; 1986 Oct; 54(1):239-44. PubMed ID: 3093385
[TBL] [Abstract][Full Text] [Related]
14. Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice.
Oishi K; Sonoda F; Iwagaki A; Kobayashi S; Nagatake T; Matsumoto K
Antimicrob Agents Chemother; 1992 Jul; 36(7):1352-7. PubMed ID: 1324643
[TBL] [Abstract][Full Text] [Related]
15. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
16. Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysaccharide O-specific side chain function differently.
Schreiber JR; Cooper LJ; Diehn S; Dahlhauser PA; Tosi MF; Glass DD; Patawaran M; Greenspan NS
J Infect Dis; 1993 Jan; 167(1):221-6. PubMed ID: 8418172
[TBL] [Abstract][Full Text] [Related]
17. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.
Pier GB; Koles NL; Meluleni G; Hatano K; Pollack M
Infect Immun; 1994 Apr; 62(4):1137-43. PubMed ID: 8132318
[TBL] [Abstract][Full Text] [Related]
18. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa.
Schreiber JR; Patawaran M; Tosi M; Lennon J; Pier GB
J Immunol; 1990 Feb; 144(3):1023-9. PubMed ID: 2104908
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mouse monoclonal antibodies directed against Pseudomonas aeruginosa lipopolysaccharides.
Sadoff JC; Wright DC; Futrovsky S; Sidberry H; Collins H; Kaufmann B
Antibiot Chemother (1971); 1985; 36():134-46. PubMed ID: 3923911
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Pseudomonas immunoglobulin on the antibacterial activity of human phagocytes].
Just HM; Termöhlen M; Pinkawa M; Daschner FD
Infection; 1987; 15 Suppl 2():S42-6. PubMed ID: 3112019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
